6H90 Stock Chart & Stats
€0.49
<€0.01(0.25%)
At close: 4:00 PM EDT
€0.49
<€0.01(0.25%)
Day’s Range― - ―
52-Week Range€0.34 - €1.02
Previous CloseN/A
Volume31.00K
Average Volume (3M)3.03K
Market Cap
€169.20M
Enterprise Value€287.49
Total Cash (Recent Filing)€39.81M
Total Debt (Recent Filing)€84.51M
Price to Earnings (P/E)―
Beta0.78
Next Earnings
Nov 16, 2026EPS Estimate
-0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.13
Shares Outstanding304,562,440
10 Day Avg. Volume997
30 Day Avg. Volume3,028
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)1.70
Price to Sales (P/S)2.03
P/FCF Ratio-10.44
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€1.17Price Target Upside138.13% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)-0.03
Revenue Forecast (FY)€84.59M
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthThe sharp first-half revenue increase shows that the Orion acquisition is materially expanding HEALWELL AI’s operating scale. A larger revenue base can support broader customer coverage, cross-selling, and more efficient deployment of its healthcare AI and analytics platform over the coming quarters.
Large Healthcare Platform ScaleExtensive patient-data coverage, clinician engagement, and provider reach create a meaningful platform foundation for clinical analytics and AI adoption. The reported identification of more than 62,000 high-risk patients also provides measurable evidence that the technology is being applied to important care-delivery use cases.
Improving Operating PerformanceThe move to positive first-half operating cash flow and materially higher adjusted EBITDA indicates that operating economics are improving after integration activity. If sustained, better cash conversion and profitability would reduce reliance on external funding and provide more capacity to invest in recurring enterprise growth.
Bears Say
Persistent Losses And Negative Free Cash FlowDespite improving recent operating results, HEALWELL AI remains loss-making and has negative trailing operating and free cash flow. This limits internal funding capacity and leaves the company exposed to execution pressure until improved margins and cash generation become consistent rather than concentrated in a recent half-year period.
Long Enterprise Sales CyclesLonger enterprise sales cycles delay contract conversions and revenue recognition, making growth less predictable across the next several quarters. The reduced growth expectation suggests that the transition toward larger recurring deals may create an extended period in which commercial momentum and resource planning remain uneven.
Integration And Margin Synergy Execution RiskThe Orion integration has delivered substantial revenue synergies, but most cost and margin benefits remain unfinished. Continued technology-debt reduction and R&D consolidation will require sustained execution, and delays could prolong margin pressure while the company works to realize the full economic value of the combined platform.
HEALWELL AI News
6H90 FAQ
What was HEALWELL AI’s price range in the past 12 months?
HEALWELL AI lowest stock price was €0.34 and its highest was €1.02 in the past 12 months.
What is HEALWELL AI’s market cap?
HEALWELL AI’s market cap is €169.20M.
When is HEALWELL AI’s upcoming earnings report date?
HEALWELL AI’s upcoming earnings report date is Nov 16, 2026 which is in 69 days.
How were HEALWELL AI’s earnings last quarter?
HEALWELL AI released its earnings results on Aug 07, 2026. The company reported €0.012 earnings per share for the quarter, beating the consensus estimate of -€0.016 by €0.028.
Is HEALWELL AI overvalued?
According to Wall Street analysts HEALWELL AI’s price is currently Undervalued.
Does HEALWELL AI pay dividends?
HEALWELL AI does not currently pay dividends.
What is HEALWELL AI’s EPS estimate?
HEALWELL AI’s EPS estimate is -0.02.
How many shares outstanding does HEALWELL AI have?
HEALWELL AI has 304,562,440 shares outstanding.
What happened to HEALWELL AI’s price movement after its last earnings report?
HEALWELL AI reported an EPS of €0.012 in its last earnings report, beating expectations of -€0.016. Following the earnings report the stock price went up 6.5%.
Which hedge fund is a major shareholder of HEALWELL AI?
Currently, no hedge funds are holding shares in DE:6H90
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
HEALWELL AI Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€1.17 (138.13% Upside)
€1.17 (138.13% Upside)
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-36.71%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-10.58%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
HEALWELL AI
Healwell AI Inc., a Toronto-based healthcare technology firm established in 2012, specializes in leveraging artificial intelligence and data science to advance preventative medical care. The company develops an AI-powered platform designed to assist healthcare providers with crucial decision-making. They maintain a significant strategic partnership with WELL Health Technologies Corp., focusing on accelerating the expansion and innovation of AI-driven healthcare solutions. Prior to its current name, adopted in October 2023, the organization was known as MCI Onehealth Technologies Inc.
6H90 Stock 12 Month Forecast
Average Price Target
€1.17
▲(138.13% Upside)
Technical Analysis
Cardiocomm Solutions
―
Reliq Health Technologies
―
Leveljump Healthcare Corp.
―
Kovo HealthTech Corporation
―
Hydreight Technologies Inc
―